Conformational Transitions upon Ligand Binding: Holo-Structure Prediction from Apo Conformations by Seeliger, Daniel & de Groot, Bert L.
Conformational Transitions upon Ligand Binding: Holo-
Structure Prediction from Apo Conformations
Daniel Seeliger, Bert L. de Groot*
Computational Biomolecular Dynamics Group, Max-Planck-Institute for Biophysical Chemistry, Go ¨ttingen, Germany
Abstract
Biological function of proteins is frequently associated with the formation of complexes with small-molecule ligands.
Experimental structure determination of such complexes at atomic resolution, however, can be time-consuming and costly.
Computational methods for structure prediction of protein/ligand complexes, particularly docking, are as yet restricted by
their limited consideration of receptor flexibility, rendering them not applicable for predicting protein/ligand complexes if
large conformational changes of the receptor upon ligand binding are involved. Accurate receptor models in the ligand-
bound state (holo structures), however, are a prerequisite for successful structure-based drug design. Hence, if only an
unbound (apo) structure is available distinct from the ligand-bound conformation, structure-based drug design is severely
limited. We present a method to predict the structure of protein/ligand complexes based solely on the apo structure, the
ligand and the radius of gyration of the holo structure. The method is applied to ten cases in which proteins undergo
structural rearrangements of up to 7.1 A ˚ backbone RMSD upon ligand binding. In all cases, receptor models within 1.6 A ˚
backbone RMSD to the target were predicted and close-to-native ligand binding poses were obtained for 8 of 10 cases in
the top-ranked complex models. A protocol is presented that is expected to enable structure modeling of protein/ligand
complexes and structure-based drug design for cases where crystal structures of ligand-bound conformations are not
available.
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Introduction
Interactions between proteins and small molecules are involved in
many biochemical phenomena. Insight into these processes relies on
detailed knowledge about the structure of protein/ligand complexes,
e.g. how enzymes stabilize substrates and cofactors in close
proximity. Moreover, almost all drugs are small-molecule ligands
that interact with enzymes, receptors or channels. Accordingly,
ligand-bound receptor complex structures are a critical prerequisite
for understanding biological function and for structure based drug
design. However, structure determination of protein/ligand-com-
plexes can be difficult, time-consuming and expensive. Crystal
structures of protein/ligand complexes are usually obtained either
by co-crystallization or soaking and it is a common problem that
even when conditions for crystallizing the apo-protein are well
established these might not be transferable to the protein/ligand
complex [1–4]. Particularly, conformational transitions of the
receptor associated with ligand binding pose a severe challenge to
the structure elucidation of holo complexes [5–8].
When structures of ligand-bound protein conformations are not
available, structure-based drug design becomes highly challenging.
Several studies showed that virtual screening to an apo-structure
usually results in a poor enrichment factor (the ability to
discriminate between binders and non-binders) compared to the
holo-structure even when the structural difference between both is
comparably small [9–11]. Therefore, the development of docking
programs aims at allowing a certain degree of receptor flexibility
either by using an ensemble of structures instead of a single
receptor conformation [12–15] or by explicitely modeling
flexibility such as sidechain variations (Autodock4 [16,17], Gold
[18,19], FlexX [20], RosettaLigand [21]), predefined flexibility of
certain parts of the structure (FlipDock [22]) and also small
variations of the backbone (Glide/Prime [23], RosettaLigand [24],
ICM [25,26]). Incorporating receptor flexibility in molecular
docking is a substantial progress and has been shown to enhance
both enrichment factors and the ability to predict correct binding
poses, particularly in cases when docking a compound to a
receptor structure that has been crystallized with a different ligand
(cross-docking) which is usually the case when searching for novel
drugs. However, the degree of flexibility thus far is limited to either
sidechain motions or small variations of the backbone and thus,
the availability of a holo-structure or an apo-structure that is
highly similar to the holo conformation is currently a prerequisite
for a successful docking, severely limiting structure-based drug
design.
Particularly, receptors that undergo a substantial conformation-
al transition upon ligand binding are currently precluded from
structure based drug design.
Although protein-ligand crystals suitable for diffraction might
not be accessible, several experimental techniques exist to detect
conformational changes. In many cases where proteins undergo
domain reorientations upon ligand binding they adopt a different
shape in the ligand bound state, corresponding to a change in the
radius of gyration that can be studied either by NMR, where a
PLoS Computational Biology | www.ploscompbiol.org 1 January 2010 | Volume 6 | Issue 1 | e1000634more compact shape causes a descrease in the rotational
correlation time [27–29] or by small-angle scattering of x-rays
(SAXS) or neutrons (SANS) [30–33]. These shape descriptions
provide invaluable information for modeling of structures [34–36]
and macromolecular assemblies [37,38] as well as insight into
protein dynamics.
Here, we present a method to predict the structure of protein/
ligand complexes for proteins that undergo a large conformational
change upon ligand binding. The protocol solely requires the apo-
structure, a known ligand and experimental data on the shape of
the holo-structure. Here, we apply the radius of gyration as shape
information, a quantity that can frequently be readily assessed
more easily than an x-ray structure. We developed a simulation
protocol that combines biased conformational sampling, docking
and molecular dynamics simulations and applied it to ten ligand-
binding proteins (see Table 1). We chose cases where both, the
unbound conformation and the bound conformation are known
from x-ray crystallography in order to be able to a-posteriori
validate the predicted receptor conformations and docking poses.
The conformational changes involved range from 2.1 to 7.1 A ˚
backbone RMSD (see table 1 and fig. 1) and the binding site
geometries differ substantially between the apo and the holo
conformations. In nine of the ten cases we predict holo receptor
conformations close to the native ligand-bound conformation
and in eight cases we predict ligand binding poses close to the
native state, rendering our method suitable for blind predictions
of protein/ligand complexes involving large conformational
transitions.
Results
The proteins used in this study undergo large conformational
changes upon ligand binding. The conformational changes involve
large domain reorientations, accompanied by loop motions and
sidechain movements. Since we use the radius of gyration as an
example of an experimentally determined constraint we chose
cases where a distinct change of this observable takes place upon
ligand binding. This is usually the case for protein motions which
are classified as hinge-bending motions according to the database
of macromolecular movements [6]. However, such a classification
is not necessary for the described protocol and is not used for the
predictions made in this work. Here, we focus at cases that
undergo domain closure upon ligand binding. With that aim,
constraints which enforce domain closure were incorporated into
the tCONCOORD program, thereby enhancing the sampling
around the closed state significantly (see Text S1).
The ten proteins used for this study belong to five different
SCOP [39–41] superfamilies.
N Periplasmic-binding protein type I: ALLO, LEU, RIBO
N Periplasmic-binding protein type II: OSMO, ALGI, GLUR2
N EPT/RTPC-like: EPSP
N P-loop containing nucleoside triphosphate hydrolase: GUA
N Actin-like ATPase domain: HEXO, GLUCO
Periplasmic-binding proteins (PBPs) mediate a wide range of
fundamental processes and are ubiquitous in bacteria. Therefore,
they are discussed as potential targets for antmicrobial agents.
Moreover, the general ‘‘Venus-flytrap’’- architecture of PBPs is
also found in the extracellular ligand-binding domain of class C G-
protein coupled receptors (GPCRs) many of which are of great
Author Summary
Structure-based drug design has become a powerful tool
in modern drug discovery pipelines. A critical prerequisite
is a structure of the target protein close to its ligand bound
conformation which is often difficult to determine
experimentally. In many cases, a structure of the unbound
receptor is available, but conformational changes with
respect to the ligand-bound form preclude it from being
used as a basis for structure-based drug design. We have
developed a computational approach to predict the
structure of protein/ligand complexes based solely on
the unbound conformation, the ligand, and easy-to-assess
experimental data. We tested our protocol on proteins that
undergo substantial structural rearrangements upon
binding a ligand and were able to predict structures of
protein/ligand complexes which are in good agreement
with experimentally determined structures. The ability to
predict ligand bound receptor conformations based on
structures in the unbound state enables structure-based
drug design for cases where crystallization of the complex
has not been successful so far.
Table 1. Comparison of apo/holo pairs of proteins.
Receptor Abbreviation PDBapo PDBholo # Res. Ligand RMSDBB RMSDBS
GluR2 ligand binding core GLUR2 1fto 1ftm 257 AMPA 2.2 2.0
DNA Beta-Glucosyl-transferase GLUCO 1jej 1jg6 351 Uridine-59-diphosphate 2.1 2.6
D-Allose binding protein ALLO 1gud 1rpj 288 D-Allose 4.4 4.0
D-Ribose binding protein RIB 1urp 2dri 271 b-D-Ribose 4.3 3.5
L-Leucine binding protein LEUB 1usg 1usi 345 Phenylalanine 7.1 6.8
5-Enolpyruvylshikimate-3-phosphate
synthase
EPSP 1rf5 1rf4 427 SPQ 3.7 4.6
Osmo-protection protein OSMO 1sw5 1sw2 270 Glycine-betaine 5.0 4.4
Guanylate kinase GUA 1ex6 1ex7 186 GMP 3.6 3.9
Hexokinase HEXO 2e2n 2e2o 298 Glucose 3.0 1.9
Alginate binding protein ALGI 1y3q 1y3n 490 Alginate Disaccharide 4.8 3.6
RMSDBB: Root mean square deviation of all backbone atoms after least square fit. RMSDBS: Root mean square deviation of the binding site. The binding site was defined
as all residues which have at least one atom within 6 A ˚ of any ligand atom.
doi:10.1371/journal.pcbi.1000634.t001
Holo Structure Prediction from Apo Conformations
PLoS Computational Biology | www.ploscompbiol.org 2 January 2010 | Volume 6 | Issue 1 | e1000634Figure 1. Overlay of apo/holo pairs and holo/model pairs. Receptor models were predicted based on the apo-structure, the ligand and the
radius of gyration of the holo conformation. Apo x-ray structures are shown in blue, holo x-ray structures are colored wheat. The best modelled
receptor structure is shown in green.
doi:10.1371/journal.pcbi.1000634.g001
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classes of kinases which represents another large group of
pharmacologically interesting receptors.
Table 1 lists the protein data bank [43] (PDB) codes of the apo/
holo pairs, their respective ligands and the global backbone root
mean square deviations (RMSD) as well as the RMSDs of the
binding site.
In all cases, the ligand binding pocket differs substantially
between the bound and the unbound state or is virtually not
present in the apo conformation. A structure prediction protocol
therefore needs to precisely predict the domain motions as well as
local structural rearrangments. We use the tCONCOORD
program [44] to generate an initial ensemble of conformations
which share a predefined radius of gyration. Since the constraints
tCONCOORD uses for the structure prediction are derived from
a given protein structure (here the apo conformation) the resulting
ensemble represents an approximation of the conformational
space that is accessible within the predefined constraints. Hence, if
interactions like hydrogen bonds are defined as constraints in the
input structure they will be conserved in the resulting ensemble. If
conformational changes are associated with partial unfolding or
refolding, resulting in major changes of, e.g. the hydrogen bond
network, the generated ensemble will be likely to miss those
conformations. Domain motions however, are ususally well
predicted [44]. The first part of the structure prediction protocol
therefore aims at predicting the correct orientation of domains.
The molecular dynamics simulations carried out subsequently
basically serve as a filter to distinguish between correct models and
those with correct geometry but unfavourable energetics which
tend to re-open quickly.
Prediction of holo receptor structures. The results are
summarized in Table 2. After the refinement cycles we find a
good correlation between the radius of gyration and the RMSD to
the holo structures (see fig 2). In all of the 10 cases the global
backbone RMSD of the best model to the known holo structure is
below 1.6 A ˚ (fig. 1). For the prediction of ligand binding poses,
however, it is more important to focus on the geometry of the
binding site. Here, we find that the prediction of the arrangement
of the backbone atoms belonging to the binding site is equal or
below 1 A ˚ RMSD accuracy in six of the ten cases and below 1.4 A ˚
in nine cases. An RMSD calculated over all atoms (including the
sidechains) corresponding to the binding site reveals RMSD values
below 2 A ˚ for nine of the ten cases. EPSP, where the backbone
deviation is 2.8 A ˚ represents a case were the current protocol
reaches its limitations since here, the structural rearrangment
between apo and holo structure involves refolding of a helix into a
loop, a transition which is not predicted by the current sampling
protocol. This causes some residues in the predicted structures to
be more than 10 A ˚ away from their target destination, hence
resulting in a large RMSD.
Prediction of ligand binding poses. Obtaining close-to-
native ligand binding poses with receptor structures obtained from
structure modeling or low-resolution data is a non-trivial task even
when close-to-native receptor conformations are available. Scoring
functions in docking programs are usually very sensitive to even
small conformational variations or structural inaccuracies and a
single misplaced sidechain can preclude successful docking.
Therefore, low binding site RMSD’s do not automatically
translate into low ligand RMSD’s. Fig. 3 shows a plot of the
ligand RMSD versus the RosettaLigand energy. As can be seen,
ligand binding poses close to the native state were sampled in all
cases but, due to structural variations in the binding site, these were
not always among the top ranked configurations. In 8 of the 10
cases,however, ligandbindingposesbelow 3 A ˚ RMSDtotheX-ray
structure are found within the top ranked solutions (see fig. 4). In
docking studies to rigid receptors ligand RMSDs of v2
0
A to the
experimentally determined binding pose are usually regarded as
successful. In our case the ligand RMSD was calculated after least
squarefittingofthemodeledcomplextothetargetstructure.Hence,
deviations of both, the modeled receptor structure and the ligand
pose contribute to the calculated ligand RMSDs.
Discussion
In this work, we present a proof of concept study that allows
successful prediction of holo-receptor conformations and ligand
binding poses. With an approach based solely on the receptor in its
unbound conformation, a known binder, such as the natural
substrate, and relatively easy to assess shape information on the
ligand-bound state, we predicted receptor models within 1.6 A ˚
RMSD to the x-ray holo structure starting from apo conforma-
tions that deviate up to 7.1 A ˚ RMSD from their respective ligand-
bound state. For 8 of the 10 cases ligand binding poses within
v3
0
A RMSD to the x-ray structure were predicted, underpinning
the applicability of our method to predict receptor models suitable
for virtual screening.
With the described protocol we bridge a gap arising from the
difficulties associated with structure determination of protein/
ligand complexes, the limited conformational flexibility that can be
incorporated in docking programs and the limited sampling that
can be achieved with molecular dynamics simulations. If apo and
holo conformations of a protein differ substantially, current
computational structure prediction approaches are usually unable
to provide accurate receptor models. As docking protocols need to
be fast to be suitable for virtual high-troughput screening they
always represent a trade-off between speed and accuracy.
Incorporation of sidechain conformational flexibility and back-
bone plasticity is a substantial progress but each additional degree
of freedom is accompanied with growing computational demand
and, hence, allowing for large conformational changes has thus for
not been feasible. Molecular dynamics simulations are in principle
capable of sampling holo conformations when starting from an
apo protein. But, in addition to the general sampling problem MD
simulations suffer from, ligands may cause alterations in the free
Table 2. Model accuracy.
Receptor
Overall BB-
RMSD
BS BB-
RMSD
BS all-atom
RMSD
Rank v v1.5 A ˚
BB
GLUR2 0.91 0.46 0.84 1
GLUCO 1.38 1.35 1.78 10
ALLO 1.07 0.96 1.55 2
RIBO 0.98 0.76 1.2 3
LEU 1.15 1.2 1.9 5
EPSP 1.58 2.8 3.58 -
OSMO 1.27 1.3 1.96 2
GUA 1.45 1.0 1.76 2
HEXO 1.42 0.87 1.38 3
ALGI 1.27 0.77 1.5 3
The table shows RMSD values for the best models. In all cases the global
backbone RMSD is below 1.6 A ˚. The backbone RMSD of the binding site is
below 1 A ˚ in 5 cases and the the RMSD calculated over all heavy atoms in the
binding site is below 2 A ˚ in 9 of 10 cases. Rank v1.5 A ˚ BB gives the rank of the
first model to get within 1.5 A ˚ RMSD to the holo x-ray structure.
doi:10.1371/journal.pcbi.1000634.t002
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landscapes of the apo protein and the protein bound to a ligand,
the sampling of close-to-holo receptor conformations without a
ligand present may be particularly poor.
The protocol described in this work combines the strengths of
docking, conformational sampling and molecular dynamics while
overcoming their particular limitations. In contrast to previous
studies [45–48] it is neither restricted to a particular type of
protein motion nor does it require the definition of rigid parts or
hinges in a structure or any other approximation. Protein
flexibility is accounted for on each level from domain motions to
sidechain fluctuations and receptors and ligands are treated as all
atom or heavy atom models in each state of the protocol. As the
sampling of large conformational transitions and crossing of
potential energy barriers is handled by the efficient concoord [49]
algorithm and MD simulations are used in refinement we gain
both efficient sampling and high accuracy within the limitations of
the force field.
The protocol furthermore allows incorporation of various
experimental data. In this work we used the radius of gyration
of the holo conformation but in principle any kind of data can be
used that is transferable into geometrical constraints, e.g. data
from FRET experiments or mutagenesis studies. Each additional
piece of information confines the sampled conformational space
and, hence enhances sampling of conformations around a
conformational state of interest (see also Text S1). Additional
improvement may be achieved by applying filters to the docked
configurations. For example, in the initial docking screens all poses
were taken into account without further screening. Analysis of the
generated poses and discarding e.g. those that are attached to the
surface rather than docked into the binding site would further
contribute to the enrichment of promising models. As in all
structure prediction protocols, sampling is the limiting factor. In
most cases, docking of the ligand to the holo x-ray structure yields
a lower score than in the modelled receptor structures. Hence, the
docking score is usually sufficient to discriminate between the
native structure and a receptor model and if the true conformation
is sampled it is most likely detectable via the docking score.
However, despite the relative simplicity to distinguish between the
true structure and a model it is very difficult to distinguish between
a model with 1 A ˚ RMSD and a model with 5 A ˚ RMSD to the
native state. When applying the current protocol to a blind
prediction it would therefore be beneficial to incorporate as much
experimental data as possible to reduce the conformational space
that needs to be explored and to enhance sampling around the true
ligand-bound conformation. The problem of conformational
sampling furthermore increases with the conformational flexibility
of the ligand. Although the ligands discussed in this work are less
complex than typical drugs they depict the necessity of very
accurate binding sites for a successful docking. Sugar ligands and
their derivatives, which some of our ligands belong to, contain
many hydroxyl groups and are almost symmetric. Thus, rotating
Figure 2. Binding-site RMSD vs. deviation from holo Rg. The deviation from the target radius of gyration correlates well with low RMSD’s to
the experimentally determined holo structures. The best receptor models (indicated by the red line) were used for binding site refinenment with
Rosetta.
doi:10.1371/journal.pcbi.1000634.g002
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interaction to the receptor but the resulting RMSD would not
characterize such a pose as a successful docking. Water molecules
can also play an important role in ligand binding. In the present
study we removed all crystallographic water molecules from the
input structures since it is quite challenging to judge which water
molecules might also be present in the ligand bound state, which
are replaced by parts of the ligand or which might even be
essential for ligand binding.
Concluding remarks. Overall, we find that our protocol is
successful in predicting close-to-native receptor models and, with
limitations, close-to-native ligand poses. Starting from apo
structures displaying global backbone RMSDs up to 7.1 A ˚ we
were able to predict holo structures within 1.6 A ˚ for all of the ten
cases and ligand poses within 3 A ˚ RMSD for 8 of the 10 proteins.
It offers a robust protocol for accurate structure prediction of
protein/ligand complexes and allows structure based drug design
for proteins that undergo large conformational changes upon
ligand binding, for which only an apo-structure and a shape
description of the holo-structure is available.
Methods
The workflow of the presented protocol combines biased
conformational sampling, docking and molecular dynamics
simulations (see fig. 5).
Biased conformational sampling. In a first step, a
conformational ensemble is generated based on the apo-
structure and the radius of gyration of the target. In this study
we did not use experimentally determined radii of gyration but
calculated them from the ligand-bound conformations according
to
Rg~
P
i
jjrijj
2mi
P
i
mi
0
B @
1
C A
1
2
where ri denotes the position of atom i with respect to the center of
mass of the protein and mi the respective mass. When using
experimentally determined values of the radius of gyration one
should be aware of the fact that these usually closely match
calculated values but are systematically larger due to the solvation
shell of the protein [50]. Larger deviations may be a hint towards
oligomerization in solution.
The conformational ensembles were generated using tCON-
COORD [44,51]. In previous studies [44,51] we showed that
tCONCOORD is able to generate structure ensembles of proteins
from a single input structure, representing a reasonable approx-
imation to the functionally relevant conformational space. The
method rests on a thorough analysis of the input structure and the
translation of conserved interactions like topological restrictions
Figure 3. Ligand RMSD’s vs. Rosetta Score. The plot shows the RMSD’s of ligand poses generated with RosettaLigand. In all cases ligand poses
below 3 A ˚ to the target structure have been sampled and in 8 cases a pose below 3 A ˚ RMSD is found within the top 100 (red) of the ranked poses.
doi:10.1371/journal.pcbi.1000634.g003
Holo Structure Prediction from Apo Conformations
PLoS Computational Biology | www.ploscompbiol.org 6 January 2010 | Volume 6 | Issue 1 | e1000634(bonds, angles), hydrogen bonds and hydrophobic clusters into
geometrical constraints with upper and lower bounds. Crystallo-
graphic water molecules were removed from the input structures
since these are often replaced by the ligand in the bound state. In a
second step, these constraints are used to rebuild the structure
starting from random atomic coordinates yielding a new structure
that fulfills all predefined constraints but differs from the input
structure, hence representing an alternative conformation. Typi-
cally, an ensemble of 100–10000 independent structures is
generated. When generating such an ensemble starting from an
apo-protein structure conformations close to the holo receptor
conformation are usually included in the ensemble.
If structural information of the ligand-bound state is available
from experimental data, it can be used as constraint to bias the
ensemble to a conformational subspace of interest [51]. A novel
implementation in tCONCOORD allows to additionally use the
radius of gyration as geometrical constraint. Thus, with a
tCONCOORD simulation using the apo-structure as input, the
radius of gyration of the ligand-bound state can be used to
enhance the probability of sampling of a conformational subspace
of interest, here the ligand-bound state. A radius of gyration bias,
however, does not represent such a strong bias as, e.g a distance
constraint which enforces a domain closure. Therefore, the
ensemble properties are relatively robust against variations of the
target radius of gyration and the tolerance used for sampling (see
Text S1 for details about biased tCONCOORD samplings).
Initial ensembles of 1000 conformations were generated with
tCONCOORD using heavy-atom representations of the receptor
structure. Constraints were defined for bonds, angles, 1–4 pairs,
hydrogen bonds that meet the desolvation stability criteria [44]
and hydrophobic clusters. The radius of gyration of the target
structure was used as additional constraint with a tolerance of
0.1 A ˚ to enhance sampling around the ligand-bound conforma-
tion. The resulting ensemble was subjected to an RMSD-
clustering to reduce the dataset to &100 conformations and each
conformation was subsequently refined using a 250 steps steepest
descent energy minimization in vacuum and 500 steps conjugate
gradient minimization in explicit solvent. Afterwards the structures
were subjected to a Rosetta refinement and scored with the ddfire
[52] scoring function. The best scoring 50 structures were selected
for resampling. The tCONCOORD resampling protocol employs
random perturbations on sidechain rotamers which are predicted
to be flexible based on interaction and packing considerations
while keeping the rest of the structure fixed. From each model, 100
conformations where generated, yielding a total number of 5000
protein conformations.
Docking and refinement. Afterwards, the known ligand was
docked into each of the 5000 models using Autodock VINA [53].
Receptor and ligand preparations were carried out using the
AutoDockTools [16]. The binding site was defined as a cubic box
of 26.25 A ˚ length placed at the center of the reference ligand
position. (Hence, for blind predictions a rough knowledge about
the location of the binding site would be required). In all cases the
docking box was large enough to guarantee independence of the
docking results from small variations of the binding site definitions.
From the docking solutions, the best 50 scoring protein/ligand
complexes were selected and subjected to 50 ps molecular
dynamics simulation with position restraints, followed by 2 ns
free simulation and 200 ps simulated annealing to 100 K.The MD
simulations were carried out with the Gromacs-4.0 [54] molecular
dynamics package in explicit solvent using the Amber03 force field
[55,56] and the tip3p water model [57]. The systems were solvated
and NaCl was added to achieve a 150 mM concentration. Ligand
parameters were obtained with the generalized Amber force field
(GAFF) approach [58]. Electrostatic interactions were calculated
at every step with the particle-mesh Ewald method [59], short-
range repulsive and attractive dispersion interactions were
simultaneously described by a Lennard-Jones potential, which
was cut off at 1.0 nm. The SETTLE [60] algorithm was used to
constrain bonds and angles of water molecules, and LINCS [61]
was used for all other bonds, allowing a time step of 2 fs. The
temperature was kept constant at 300 K by weakly coupling the
system to an external heat bath [62,63] (time constant t~0:1ps)
and the pressure was kept constant at 1 atm by weak isotropic
coupling to a pressure bath (t~1ps).
The resulting structures were ranked by their compliance with
the target radius of gyration and the best 10 models were subjected
to a second refinement cycle consisting of resampling, docking
Figure 4. Modeled protein/ligand complexes. X-ray structures of
receptor and ligand are shown in wheat and yellow, modeled
complexes are colored green/blue.
doi:10.1371/journal.pcbi.1000634.g004
Holo Structure Prediction from Apo Conformations
PLoS Computational Biology | www.ploscompbiol.org 7 January 2010 | Volume 6 | Issue 1 | e1000634and, after filtering the best poses, to molecular dynamics
refinement.
Model assessment and binding site refinement.
From the resulting receptor structures the radius of gyration
was calculated and those models that had less than 1% deviation
from the holo radius of gyrations were chosen for a binding site
refinement (In two cases we chose a larger Rg-cutoff since no
models were obtained within 1%). For the refinment we carried
out docking to the rigid receptor structures and used
RosettaLigand to refine the docking pose while simultaneously
repacking the sidechains around the ligand. 100 conformations
were generated based on each ligand pose and the resulting
complexes were ranked according to the RosettaLigand score.
The current protocol requires about four days per case on a 50
node cluster with the most time spent in the molecular dynamics
part and the QM based ligand parametrization with gaussian
[58,64].
Supporting Information
Figure S1 Comparison of free and biased tCONCOORD
samplings of D-Ribose binding protein.
Found at: doi:10.1371/journal.pcbi.1000634.s001 (1.39 MB TIF)
Text S1 Comparison of different biased and unbiased sampling
protocols in tCONCOORD.
Found at: doi:10.1371/journal.pcbi.1000634.s002 (0.02 MB PDF)
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